Abbisko Cayman Limited (HKG:2256)
Hong Kong
· Delayed Price · Currency is HKD 9.36
-0.45 (-4.59%)
Jun 26, 2026, 4:08 PM HKT
Abbisko Cayman Employees
Abbisko Cayman had 276 employees as of December 31, 2025. The number of employees decreased by 5 or -1.78% compared to the previous year.
Employees
276
Change (1Y)
-5
Growth (1Y)
-1.78%
Revenue / Employee
2.47M HKD
Profits / Employee
222.75K HKD
Market Cap
6.71B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 276 | -5 | -1.78% |
| Dec 31, 2024 | 281 | 23 | 8.91% |
| Dec 31, 2023 | 258 | 8 | 3.20% |
| Dec 31, 2022 | 250 | 90 | 56.25% |
| Dec 31, 2021 | 160 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Shanghai Haohai Biological Technology | 2,110 |
| Alphamab Oncology | 498 |
| Lepu Biopharma | 710 |
| CStone Pharmaceuticals | 136 |
| Suzhou Ribo Life Science | 407 |
| CARsgen Therapeutics Holdings | 355 |
| CK Life Sciences Int'l., (Holdings) | 1,920 |
| Everest Medicines | 812 |
Abbisko Cayman News
- 5 days ago - Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly - Reuters